BCPC Balchem Corporation

Balchem Corporation Acquires Zumbro River Brand, Inc.

Balchem Corporation Acquires Zumbro River Brand, Inc.

NEW HAMPTON, N.Y., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced the acquisition of Zumbro River Brand, Inc. (“Zumbro”), headquartered in Albert Lea, MN. Zumbro specializes in developing, marketing, and manufacturing agglomerated and extruded products for the food and beverage industry and is a market leader in high protein and specialty extruded snacks, cereals, and crisps, marketed under the brands Z-Crisps®, Whey-Os™, Whey-Vs™, and Z-Texx Complete™.

Ted Harris, Chairman, CEO, and President of Balchem, said, “Zumbro’s products, brands, and manufacturing capabilities will further enhance our portfolio of solutions for our customers in the food and beverage industry. Mr. Harris added, “In particular, the unique high protein products and extrusion manufacturing capabilities that Zumbro has developed will expand our ability to provide custom solutions for the higher protein nutritional needs of the market today. We are excited to bring these technologies, and the full line of Balchem solutions, to all of our customers.”

Pam Sander, majority owner and Chief Executive Officer of Zumbro, said, "Zumbro's rapid growth in plant-based proteins and better-for-you snacks was achieved thanks to our dedicated, innovative employees. We're excited to be joining Balchem, an industry leader that shares our vision for the tremendous opportunities for these products, and can help to scale these eco- and health-friendly choices to the broader market."

Zumbro will be integrated within Balchem’s Human Nutrition and Health Segment.

About Balchem Corporation

Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports four business segments: Human Nutrition & Health; Animal Nutrition & Health; Specialty Products; and Industrial Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market. The Industrial Products segment manufactures and supplies certain derivative products into industrial applications. For more information please visit

Forward-Looking Statement

This release contains forward-looking statements, which reflect Balchem’s expectation or belief concerning future events that involve risks and uncertainties. Balchem can give no assurance that the expectations reflected in forward-looking statements will prove correct and various factors could cause results to differ materially from Balchem’s expectations, including risks and factors identified in Balchem’s annual report on Form 10-K for the year ended December 31, 2018. Forward-looking statements are qualified in their entirety by the above cautionary statement. Balchem assumes no duty to update its outlook or other forward-looking statements as of any future date.

Contact: 

Mary Ann Brush, Executive Assistant to CEO

Telephone: 845-326-5600

E-mail: 

 

EN
16/12/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Balchem Corporation

 PRESS RELEASE

Statement on new EU choline chloride anti-dumping measures

Statement on new EU choline chloride anti-dumping measures EU producers laud EU for addressing choline chloride dumping by China; measures will help preserve jobs and secure feed supply chain MONTVALE, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- As producers of choline chloride in the EU, Eastman and Balchem welcome the European Union's decision published on December 19, 2025 to adopt anti-dumping duties between 90.0 and 115.9% on choline chloride imports from the People's Republic of China. This decision, which will be effective for five years with the possibility of renewal, confirms Euro...

 PRESS RELEASE

Balchem Corporation Announces Dividend

Balchem Corporation Announces Dividend MONTVALE, N.J., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that on December 9, 2025, its Board of Directors declared a dividend on its shares of common stock equal to $0.96 per share on the Company’s issued and outstanding Common Stock, to be payable on January 20, 2026 to stockholders of record at the close of business on December 23, 2025. This dividend represents an 10.3% increase over last year’s annual dividend. Ted Harris, Balchem’s Chairman, President and CEO, said, “Balchem has a longstanding commitm...

 PRESS RELEASE

Balchem Corporation to Present at Baird’s 55th Annual Global Industria...

Balchem Corporation to Present at Baird’s 55th Annual Global Industrial Conference on November 12, 2025 MONTVALE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at Baird’s 55th Annual Global Industrial Conference on November 12, 2025. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations, will present at the conference. About Balchem Co...

 PRESS RELEASE

Balchem Corporation Reports Third Quarter 2025 Financial Results

Balchem Corporation Reports Third Quarter 2025 Financial Results MONTVALE, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2025 fiscal third quarter ended September 30, 2025. For the quarter, the Company reported net sales of $267.6 million, net earnings of $40.3 million, adjusted EBITDA(a) of $71.4 million, and free cash flow(a) of $50.7 million. Ted Harris, Chairman, President and CEO of Balchem said, “In the third quarter, our company continued to deliver strong growth, fueled by the ongoing market penetration of our ...

 PRESS RELEASE

Balchem Corporation Announces Quarterly Conference Call for Third Quar...

Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2025 Financial Results on October 21, 2025 MONTVALE, N.J., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Tuesday, October 21, 2025, at 11:00 AM Eastern Time (ET) to review third quarter 2025 results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. Third quarter results will be published prior to the market opening on Tuesday, October 21, 2025. The press release, and its accompanying fin...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch